BridgeBio Oncology Therapeutics, Inc 10-Q for FY2026 Q2
BridgeBio Oncology Therapeutics, Inc. (BBOT)
10-Q
2026-08-11
For: 2026-06-30
View Original
Added on
August 11, 2026
About this 10-Q
BridgeBio Oncology Therapeutics, Inc filed this 10-Q on August 11, 2026, covering the quarter ended June 30, 2026 (FY2026 Q2).
Headline figures
Quarter ended June 30, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Net loss
- $56.45M
- compared with a net loss of $28.44M a year earlier
- Diluted EPS
- -$705.20
- compared with -$566.46 a year earlier